Association between HER2 heterogeneity and clinical outcomes of HER2-positive gastric cancer patients treated with trastuzumab

医学 内科学 曲妥珠单抗 免疫组织化学 肿瘤科 队列 胃肠病学 癌症 外科肿瘤学 乳腺癌
作者
Kyunghye Bang,Jaekyung Cheon,Young Soo Park,Hyung‐Don Kim,Min‐Hee Ryu,Yangsoon Park,Meesun Moon,Hyungeun Lee,Yoon‐Koo Kang
出处
期刊:Gastric Cancer [Springer Nature]
卷期号:25 (4): 794-803 被引量:17
标识
DOI:10.1007/s10120-022-01298-6
摘要

The GASTHER1 study showed that re-evaluation of HER2 status rescued 8% of HER2-positive gastric cancer (GC) patients with initially HER2-negative GC. Since rescued HER2 positivity represents HER2 heterogeneity, we aimed to investigate this in a larger cohort with longer follow-up duration.Data of 153 HER2-positive advanced GC patients who received first-line trastuzumab-based chemotherapy were analyzed. Repeat endoscopic biopsy was performed in patients with initially HER2-negative GC. Survival outcomes were analyzed according to the immunohistochemistry (IHC) score (IHC 2+ /in situ hybridization [ISH] + vs IHC 3+), HER2 status (initially vs rescued HER2 positive), and H-score.IHC 2+ /ISH + patients showed worse progression-free survival (PFS) and overall survival (OS) than those with IHC 3+ (p < 0.05). Rescued HER2-positive patients showed worse PFS and OS than initially HER2-positive patients (p < 0.05). Although survival outcomes were comparable according to HER2 status in IHC 2+ /ISH + patients, initially HER2-positive patients showed more favorable PFS and OS than rescued HER2-positive patients (p < 0.05) among those with IHC 3+ . Among the subgroups determined by HER2 status and IHC score, the initially IHC 3+ subgroup had the highest H-score. The low H-score group (H-score ≤ 210) had significantly worse survival outcomes than the high H-score group (H-score > 210) (p < 0.05). An H-score of ≤ 210 was independently associated with shorter OS (HR = 1.54, 95% CI 1.02-2.31, p = 0.04).Rescued HER2-positive patients showed worse clinical outcomes than initially HER2-positive patients, especially those with IHC 3+ . This finding highlights the impact of HER2 heterogeneity, which can be quantified indirectly as an H-score.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI2S应助Rex采纳,获得10
刚刚
可爱的函函应助派大星采纳,获得10
刚刚
刚刚
夏夏完成签到 ,获得积分20
2秒前
上好佳发布了新的文献求助10
4秒前
4秒前
完美采梦完成签到 ,获得积分10
4秒前
毛小驴完成签到,获得积分10
5秒前
今后应助科研通管家采纳,获得10
5秒前
科研通AI2S应助科研通管家采纳,获得10
5秒前
CipherSage应助科研通管家采纳,获得10
5秒前
搜集达人应助科研通管家采纳,获得10
5秒前
6秒前
劲秉应助科研通管家采纳,获得20
6秒前
6秒前
畅快日记本完成签到,获得积分10
6秒前
sx完成签到,获得积分10
7秒前
阿丽发布了新的文献求助10
7秒前
9秒前
大男完成签到,获得积分10
10秒前
wang完成签到,获得积分10
10秒前
12秒前
13秒前
糊涂涂完成签到,获得积分10
13秒前
14秒前
16秒前
蔡鑫完成签到 ,获得积分10
17秒前
18秒前
独特伟泽完成签到,获得积分10
19秒前
19秒前
周周发布了新的文献求助10
20秒前
20秒前
21秒前
传奇3应助椰子汁采纳,获得10
23秒前
独特伟泽发布了新的文献求助10
23秒前
沉静妙之完成签到 ,获得积分10
24秒前
王术完成签到,获得积分10
24秒前
斯文败类应助life采纳,获得10
24秒前
爱学习的汤姆猫完成签到,获得积分10
26秒前
科研通AI2S应助路程采纳,获得10
27秒前
高分求助中
Spray / Wall-interaction Modelling by Dimensionless Data Analysis 2000
Mixed-anion Compounds 600
ALA生合成不全マウスでの糖代謝異常の分子機構解析 520
Aspects of Babylonian celestial divination: the lunar eclipse tablets of Enūma Anu Enlil 500
Geochemistry, 2nd Edition 地球化学经典教科书第二版 401
Management of cardiopulmonary bypass 400
2024 Medicinal Chemistry Reviews 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3199162
求助须知:如何正确求助?哪些是违规求助? 2848029
关于积分的说明 8066187
捐赠科研通 2512827
什么是DOI,文献DOI怎么找? 1344946
科研通“疑难数据库(出版商)”最低求助积分说明 639938
邀请新用户注册赠送积分活动 609663